CAVE CREEK, AZ, April 06, 2020 -- CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to provide a quarterly update on its operations and announce that its latest interview with Jane King is now publicly available.
The full interview may be found here: https://www.youtube.com/watch?v=DyNHlved1Gw
The Company generated over a million in quarterly sales, which illustrates an accelerated growth curve year-over-year. The Company landed a million-dollar deal in its second quarter and is pleased to recognize the revenues this quarter.
First Quarter FY2020 Milestones and Highlights:
CBD Unlimited’s CEO and Chairman, Todd Davis, re-joined Jane King to provide an update on the Company’s market store expansion, national and international growth strategy, subscription model, product suite update and its rapidly growing e-commerce platform. Natural food stores, grocery chains, and big-box pharmacies are reordering CBD Unlimited’s innovative product line of scientifically formulated CBD enhanced topicals.
“During this unprecedented time, we hope that everyone is continuing to focus on their long-term health and wellness. During this quarter, we achieved impressive sales and orders directly related to our market store expansion strategy. We forecast that CBD Unlimited will again hit its year-end goal of 20,000 stores roughly 2-5 months early. In addition, our revamped e-commerce website now allows online shoppers to locate the nearest store that carries CBD Unlimited products as well as order online,” commented CBD Unlimited’s Chief Executive Office and Chairman, Todd Davis.
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity while reducing costs for retailers and costs in time for customers.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.